What is Charles River Laboratories?
Charles River Laboratories is a drug discovery and non-clinical development services company company serving enterprise, commercial, consumer, healthcare, financial, real estate, or regulated-market customers.
- Category
- Drug discovery and non-clinical development services company
- Headquarters
- Wilmington, United States
- Founded
- See official company history
- Employees
- See latest annual report and company filings
- Total funding
- Public company
- Status
- Public company; NYSE: CRL
What is Charles River Laboratories?
Charles River Laboratories is a drug discovery and non-clinical development services company company headquartered in Wilmington, United States. Its public-company profile is most useful for account planning when combined with current filings, investor materials, job posts, product launches, and partner announcements.
Charles River Laboratories is a drug discovery and non-clinical development services company company headquartered in Wilmington, United States. Its public-company profile is most useful for account planning when combined with current filings, investor materials, job posts, product launches, and partner announcements.
For sellers, Charles River Laboratories should be mapped as a scaled public-company account. The best timing signals are earnings commentary, capital spending, hiring clusters, product launches, acquisitions, facility investments, and leadership changes.
What does Charles River Laboratories offer?
Charles River Laboratories's profile centers on Preclinical research, Discovery services, Safety assessment, Lab models.
- Preclinical research· Drug discovery and non-clinical development services company
- Discovery services· Drug discovery and non-clinical development services company
- Safety assessment· Drug discovery and non-clinical development services company
- Lab models· Drug discovery and non-clinical development services company
- Biologics testing· Drug discovery and non-clinical development services company
- CRO services· Drug discovery and non-clinical development services company
How does Charles River Laboratories make money?
Charles River Laboratories makes money through commercial activity tied to drug discovery and non-clinical development services company.
Charles River Laboratories monetizes through the model common to drug discovery and non-clinical development services company: product sales, recurring services, contracts, leases, subscriptions, transaction volume, servicing, investment management, or usage depending on the operating unit.
Sales angles should connect to measurable priorities such as margin, growth, occupancy, compliance, retention, automation, risk reduction, data quality, customer experience, or field productivity.
Who leads Charles River Laboratories?
Charles River Laboratories's named executives should be verified on the official leadership or investor-relations page before outreach.
- Charles River Laboratories executive leadershipExecutive leadership teamCurrent as of June 2026Use the official leadership, governance, or investor-relations page for current named executives before outreach.
- Charles River Laboratories finance leadershipFinance / CFO organizationCurrent as of June 2026Often owns investor communication, procurement governance, capital allocation, and budget discipline.
- Charles River Laboratories operations or technology leadershipOperations, product, technology, security, or commercial leadershipCurrent as of June 2026Likely stakeholder group for software, infrastructure, data, workflow, and operating-improvement purchases.
How do you contact Charles River Laboratories's leadership?
Charles River Laboratories should be contacted through official investor, media, partner, support, or sales routes unless a named executive publishes a direct address.
contact via https://www.criver.com- Charles River Laboratories investor relationsInvestor relations / corporate contactcontact via https://www.criver.com
- Charles River Laboratories sales or partnershipsCommercial contact routecontact via https://www.criver.com
- Charles River Laboratories media relationsMedia or communications contact routecontact via https://www.criver.com
How is Charles River Laboratories funded?
Charles River Laboratories's current status is Public company; NYSE: CRL.
Charles River Laboratories's capital profile is best understood through its current public-company status: Public company; NYSE: CRL. For public companies, financing and budget signals are usually found in annual reports, quarterly results, debt disclosures, buybacks, acquisitions, capital expenditure plans, and management commentary rather than venture funding rounds.
Before outreach, verify the latest status on the company's investor-relations page and current exchange filings.
How did Charles River Laboratories get here?
Charles River Laboratories's history should be read through founding, scale-up, public-market ownership, and current product or market focus.
- FoundingCharles River Laboratories is foundedThe company begins building in drug discovery and non-clinical development services company.
- Scale-upCommercial footprint expandsCharles River Laboratories broadens its product, customer, distribution, or geographic reach.
- Public marketsPublic company; NYSE: CRLPublic-company ownership shapes reporting, procurement, and operating priorities.
- 2025Scaled operating profileThe company operates with specialized teams and repeatable buying centers.
- June 2026Current profile refreshedProfile generated from official domain, public-company status, and source references.
Who are Charles River Laboratories's competitors?
Charles River Laboratories competes with larger incumbents and focused specialists in drug discovery and non-clinical development services company.
Charles River Laboratories — frequently asked questions
